Overrepresentation analysis resulted in “glucose metabolism” (FDR: 0.0514), TFs E2F transcription factor 1 (E2F1, FDR: 0.0457) and Signal transducer and activator of transcription 5 (STAT5, FDR: 0.0557) in those microRNAs downregulated in CML-CP HSC (Table 2). This evidence concerns the gene E2F1 and chronic myelogenous leukemia, BCR-ABL1 positive.